L-carnitine in children with idiopathic dilated cardiomyopathy

Indian Heart Journal

Volumn 50, Issue 1, 1998, Pages 59-61

  Kothari, Shyam S ^a   Sharma, Mukti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; PRESCHOOL CHILD;

CARDIOMYOPATHY, DILATED; CARNITINE; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0031813848     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fernandez C, Proto C. L-carnitine in the treatment of chronic myocardial ischaemia: An analysis of 3 multi-centre studies and a bibliographic review. Clin Ther 1992; 140: 353-377
2. Fujiwara M, Nakaano T, Tamoto S, Yamada Y, Fukai M, Takada K, Ashida H, Shimada T, Ishikara T, Sehi I. Effects of L-carnitine in patients with ischaemic heart disease. J Cardiol 1991; 21: 493-504
3. Davini P, Bigalli A, Lamanna F, Boem A. Control study on L-carnitine therapeutic efficacy in postinfarction. Drugs Exp Clin Rev 1992; 18: 355-365
4. Regitz V, Shug AL, Fleck E. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart disease. Am J Cardiol 1990; 65: 755-760
5. Zales VR, Benson DW Jr. Reversible cardiomyopathy due to carnitine deficiency from renal tubular wasting. Pediatr Cardiol 1995; 16: 76-78
6. Vikre-jorgensen J. Cardiomyopathy caused by carnitine deficiency. Ugeskr Laeger 1993; 155: 3390-3392
7. Kader K, Malegh B, Sezendrei E, Herczegfalvi A. Carnitine deficient cardiomyopathy. Orv Hetil 1994; 135: 473-474
8. McCarty MF. Fish oil and other nutritional adjuvants for treatment of congestive heart failure. Med Hypothesis 1996; 46: 400-406
9. Kobayashi A, Fujisawa S. Effects of L-carnitine on mitochondrial acyl CoA esters in the ischaemic dog heart J Mol Cell Cardiol 1994; 26: 499-508
10. Broderick TL, Panagakis G, Didomenica D, Gamble J, Lopaschuck GD, Shug AL, Poison DJ. L-carnitine improvement of cardiac function is associated with stimulation in glucose but not fatty acid metabolism in carnitine deficient hearts. Cardiovasc Res 1995; 30: 815-820
11. Weber L, Valle D, Neil C. Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport. J Pediatr 1982; 101: 700-705
12. Ino T, Sherwood WG, Benson LN. Cardiac manifestations in disorders of fat and carnitine metabolism in infancy. J Am Coll Cardiol 1988; 11: 1301-1308
13. Ostman-Smith I, Brown G, Johnson A, Land JM. Dilated cardiomyopathy due to type II x-linked 3-methylglutaconic aciduria successful treatment with pantothenic acid. Br Heart J 1994; 72: 349-353
14. Ghidini O, Azzurro M, Vita G, Sartori G. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure. Int J Clin Pharmacol Ther Toxicol 1988; 26: 218-220